Brief: Allergy Therapeutics Remains Confident In Delivering Revenue Growth In Year To 30 June 2026
19/01/2026 07:30
Jan 19 (Reuters) - Allergy Therapeutics PLC AGY.L: ALLERGY THERAPEUTICS - HALF YEAR TRADING UPDATE ALLERGY THERAPEUTICS PLC - REMAINS CONFIDENT IN DELIVERING REVENUE GROWTH IN YEAR TO 30 JUNE 2026 Source text: ID:nRSS3295Pa Further company coverage: AGY.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allergy Therapeutics
See all newsBrief: Allergy Therapeutics Expects FY 2026 Revenue Of £59.90 Million, Up 9% Reported
UK's Allergy Therapeutics FY revenue beats on Grassmuno launch
Allergy Therapeutics - Trading update for the year ended 30 June 2026
Brief: Allergy Therapeutics Appoints Helge Weiner-Trapness As Executive Chairman
Allergy Therapeutics - Appointment of Executive Chairman